| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.04 |